FindTrial
Sign In

Curcumin inhibits proliferation and invasion of MG63 cells through inactivation of pJAK-2/pSTAT-3 pathway

Curcumin inhibits proliferation and invasion of MG63 cells through inactivation of pJAK-2/pSTAT-3 pathway

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018262
Enrollment
Unknown
Registered
2018-09-07
Start date
2018-09-30
Completion date
Unknown
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteosarcoma

Interventions

Case series:curcumin

Sponsors

Affiliated Sixth People's Hospital, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Primary and secondary malignant tumors of bone

Exclusion criteria

Exclusion criteria: None surgery treatment of primary and secondary malignant tumors of bone

Design outcomes

Primary

MeasureTime frame
Antigen expression;—

Countries

China

Contacts

Public ContactYuanjue Sun

Affiliated Sixth People's Hospital, Shanghai Jiaotong University

sunyuanjue@163.com+86 13917991091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026